Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.

MLA

Chung, Moon Jae, et al. “Phase II Clinical Trial of Ex Vivo-Expanded Cytokine-Induced Killer Cells Therapy in Advanced Pancreatic Cancer.” Cancer Immunology, Immunotherapy : CII, vol. 63, no. 9, Sept. 2014, pp. 939–46. EBSCOhost, https://doi.org/10.1007/s00262-014-1566-3.

APA

Chung, M. J., Park, J. Y., Bang, S., Park, S. W., & Song, S. Y. (2014). Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer. Cancer Immunology, Immunotherapy : CII, 63(9), 939–946. https://doi.org/10.1007/s00262-014-1566-3

Chicago

Chung, Moon Jae, Jeong Youp Park, Seungmin Bang, Seung Woo Park, and Si Young Song. 2014. “Phase II Clinical Trial of Ex Vivo-Expanded Cytokine-Induced Killer Cells Therapy in Advanced Pancreatic Cancer.” Cancer Immunology, Immunotherapy : CII 63 (9): 939–46. doi:10.1007/s00262-014-1566-3.